Basic Information
ID: ALA4194085
Type: Functional
Description: Cytotoxicity against human A549 cells assessed as reduction in cell viability using compound addition to cell culture cells in log phase of growth and incubated for 48 hrs by MTT assay
Organism: Homo sapiens
Cell type: A549
Activity Charts
Bioactivity
Activity Types for Assay ALA4194085
IC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 152.18 | 0.64 | 0.64 |
| 1255.44 | ||
| 470.61 | 3.35 | 3.35 |
| 502.65 | 3.20 | 3.20 |
| 488.62 | 2.55 | 2.55 |
| 472.62 | 3.58 | 3.58 |
| 512.64 | 3.92 | 3.92 |
| 507.07 | 3.55 | 3.55 |
| 584.87 | ||
| 470.61 | 3.40 | 3.40 |
| 554.68 | 4.49 | 4.49 |
| 510.63 | 4.13 | 4.13 |
| 549.10 | 4.12 | 4.12 |
| 510.67 | 4.32 | 4.32 |
| 667.89 | 6.26 | 6.26 |
| 610.79 | 6.05 | 6.05 |
| 577.76 | 4.35 | 4.35 |
| 723.00 | 9.18 | 9.18 |
| 486.61 | 2.56 | 2.56 |
| 564.68 | 4.81 | 4.81 |
| 695.65 | 6.55 | 6.55 |
| 633.27 | 6.47 | 6.47 |
| 474.64 | 3.37 | 3.37 |
| 552.71 | 5.16 | 5.16 |
| 503.64 | 2.05 | 2.05 |
| 574.71 | 5.22 | 5.22 |
| 484.63 | 4.01 | 4.01 |
| 526.67 | 4.31 | 4.31 |
| 698.81 | 4.36 | 4.36 |
| 503.64 | 2.05 | 2.05 |
| 540.70 | 4.70 | 4.70 |
| 624.77 | 6.37 | 6.37 |
| 775.34 | 7.30 | 7.30 |
| 835.22 | 12.30 | 12.30 |
| 489.05 | 4.60 | 4.60 |
| 621.33 | ||
| 591.54 | 4.30 | 4.30 |
| 468.59 | 3.56 | 3.56 |
| 484.63 | 4.01 | 4.01 |
| 524.65 | 4.52 | 4.52 |
| 638.84 | 6.55 | 6.55 |
| 601.14 | 5.01 | 5.01 |
| 582.73 | 5.27 | 5.27 |
| 584.71 | 3.86 | 3.86 |
| 653.61 | 5.98 | 5.98 |
| 472.62 | 3.14 | 3.14 |
| 778.94 | 9.39 | 9.39 |
| 641.20 | 5.43 | 5.43 |
| 502.60 | 1.78 | 1.78 |
| 484.63 | 4.01 | 4.01 |
| 466.57 | 3.77 | 3.77 |
| 516.68 | 3.86 | 3.86 |
| 543.75 | 3.95 | 3.95 |
| 652.91 | 7.82 | 7.82 |
| 572.70 | 5.43 | 5.43 |
| 602.89 | ||
| 554.72 | 4.95 | 4.95 |
| 759.46 | 9.38 | 9.38 |
| 458.64 | 4.40 | 4.40 |
| 735.27 | 4.56 | 4.56 |
| 658.74 | 6.27 | 6.27 |
| 538.68 | 4.91 | 4.91 |
| 603.76 | 5.26 | 5.26 |
| 507.50 | 5.85 | 5.85 |
| 456.62 | 4.60 | 4.60 |